 |
O-(3-piperidino-2-hydroxyl-1-propyl)-nicotinic acid amidoxime hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Duchenne muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2013-01-15 00:00:00 |
| Sponsor | Vudbenk Life Sciences;Tancsics Mihaly utca 18, 5900 Oroshaza; |
